SN
Sunil Nankar
Also known as: Sunil Ashok Nankar
Alvotech Biosciences India Ltd, Dr. Reddy's Laboratories (India), National Institute of Pharmaceutical Education and Research, NDMVP Samaj's College of Pharmacy, Intas Pharmaceuticals Ltd
Employment
-
Alvotech Biosciences India Ltd External Development Lead2022 - Present
-
Dr. Reddy's Laboratories (India) Scientific Lead2019 - 2022
-
Intas Pharmaceuticals Ltd Principal Scientist2016 - 2019
-
Wockhardt Research Centre Research Scientist2014 - 2016
Education
-
National Institute of Pharmaceutical Education and Research M.S. (Pharm.)2007 - 2009
-
NDMVP Samaj's College of Pharmacy B.Pharm.2004 - 2007
-
North Maharashtra University Smt Sharadchandrika Suresh Patil College of Pharmacy Chopda D. Pharm.2002 - 2004
Projects & Funding
Projects & funding information is unavailable.
Publications (8)
- Apolipoprotein-mimetic Peptides: Current and Future Prospectives Save
- HDL, ApoA-I and ApoE-Mimetic Peptides: Potential Broad Spectrum Agent for Clinical Use? Save
- ApoE-Derived Peptides Attenuated Diabetes-Induced Oxidative Stress and Inflammation Save
- Properties of apolipoprotein E derived peptide modulate their lipid-binding capacity and influence their anti-inflammatory function. Save
- Apolipoprotein E derived peptides inhibit the pro-inflammatory effect of lysophosphatidylcholine. Save
- Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs. Save
- Physicochemical properties of bacterial pro-inflammatory lipids influence their interaction with apolipoprotein-derived peptides. Save
- Membrane surface charge modulates lipoprotein complex forming capability of peptides derived from the C-terminal domain of apolipoprotein E. Save